Merck to acquire Inspire Pharmaceuticals
Merck plans to buy Inspire Pharmaceuticals Inc., a specialty pharmaceutical company focused on ophthalmic products. Under the agreement announced Tuesday, Merck, through a subsidiary, will commence a tender offer for all outstanding common stock of Inspire.